Low testosterone linked to higher risk of aggressive prostate cancer progression — clinical nuance
Key Questions
How is low testosterone linked to prostate cancer progression?
In a cohort of 924 men on active surveillance for localized prostate cancer, baseline total testosterone ≤300 ng/dL was associated with about 61% higher risk of aggressive progression. This retrospective study highlights low T as a potential risk factor.
What does this mean for men considering testosterone optimization?
The findings complicate messaging on testosterone therapy in older men, emphasizing the need for individualized risk/benefit assessments. Appropriate prostate screening and surveillance are crucial before pursuing T-targeted interventions, with informed consent required.
What are the key details of the study on low testosterone and prostate cancer?
The retrospective study involved over 900 men with localized prostate cancer on active surveillance. It found low testosterone levels correlated with significantly higher risks of aggressive disease progression, underscoring clinical nuance in management.
n=924 active surveillance cohort: baseline T≤300 ng/dL ~61% higher aggressive progression risk. Individualize T interventions in older men w/ screening/surveillance.